These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 37568347)

  • 41. Cardiotoxicity of Contemporary Breast Cancer Treatments.
    Lee Chuy K; Yu AF
    Curr Treat Options Oncol; 2019 May; 20(6):51. PubMed ID: 31073788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Mechanisms of cardiotoxicity of oncological therapies].
    Lehmann LH; Fröhling S
    Internist (Berl); 2020 Nov; 61(11):1132-1139. PubMed ID: 33034675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic Imaging in Cardio-oncology.
    Tong D; Zaha VG
    J Cardiovasc Transl Res; 2020 Jun; 13(3):357-366. PubMed ID: 31696405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity.
    Wickramasinghe CD; Nguyen KL; Watson KE; Vorobiof G; Yang EH
    Future Oncol; 2016 Mar; 12(6):855-70. PubMed ID: 26829050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardio-Oncology: Managing Cardiovascular Complications of Cancer Therapies.
    Sharma R; Kashyap J; Olanrewaju OA; Jabbar A; Someshwar F; Saeed H; Varrassi G; Qadeer HA; Kumar S; Cheema AY; Khatri M; Wazir M; Ullah F
    Cureus; 2023 Dec; 15(12):e51038. PubMed ID: 38269231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardio-Oncology Services: rationale, organization, and implementation.
    Lancellotti P; Suter TM; López-Fernández T; Galderisi M; Lyon AR; Van der Meer P; Cohen Solal A; Zamorano JL; Jerusalem G; Moonen M; Aboyans V; Bax JJ; Asteggiano R
    Eur Heart J; 2019 Jun; 40(22):1756-1763. PubMed ID: 30085070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
    Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
    Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection.
    Morelli MB; Bongiovanni C; Da Pra S; Miano C; Sacchi F; Lauriola M; D'Uva G
    Front Cardiovasc Med; 2022; 9():847012. PubMed ID: 35497981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring the Cardiotoxicity Spectrum of Anti-Cancer Treatments: Definition, Classification, and Diagnostic Pathways.
    Mauro C; Capone V; Cocchia R; Cademartiri F; Riccardi F; Arcopinto M; Alshahid M; Anwar K; Carafa M; Carbone A; Castaldo R; Chianese S; Crisci G; D'Assante R; De Luca M; Franzese M; Galzerano D; Maffei V; Marra AM; Mazza A; Ranieri B; D'Agostino A; Rega S; Romano L; Scagliarini S; Sepe C; Vriz O; Izzo R; Cittadini A; Bossone E; Salzano A
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular imaging in cardio-oncology.
    Tamaki N; Manabe O; Hirata K
    Jpn J Radiol; 2024 Aug; ():. PubMed ID: 39207643
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Utility of Advanced Cardiovascular Imaging in Cancer Patients-When, Why, How, and the Latest Developments.
    Yu C; Pathan F; Tan TC; Negishi K
    Front Cardiovasc Med; 2021; 8():728215. PubMed ID: 34540922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of cardiac biomarkers in cardio-oncology.
    Riddell E; Lenihan D
    Curr Probl Cancer; 2018 Jul; 42(4):375-385. PubMed ID: 30126650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rationale and proposal for cardio-oncology services in Italy.
    Galderisi M; Santoro C; Bossone E; Mancusi C
    J Cardiovasc Med (Hagerstown); 2022 Apr; 23(4):207-215. PubMed ID: 32858628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modern concepts in cardio-oncology.
    Rassaf T; Totzeck M
    J Thorac Dis; 2018 Dec; 10(Suppl 35):S4386-S4390. PubMed ID: 30701105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity.
    Minasian L; Dimond E; Davis M; Adhikari B; Fagerstrom R; Fabian C; Floyd J; Unger JM; Douglas PS; Mustian KM; Chow EJ; Lipshultz S; Hundley WG; Armenian S; Ky B
    JACC CardioOncol; 2019 Sep; 1(1):105-113. PubMed ID: 32529192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.
    Bergler-Klein J; Rainer PP; Wallner M; Zaruba MM; Dörler J; Böhmer A; Buchacher T; Frey M; Adlbrecht C; Bartsch R; Gyöngyösi M; Fürst UM
    Wien Klin Wochenschr; 2022 Sep; 134(17-18):654-674. PubMed ID: 35507087
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An Overview of Cardio-Oncology, a New Frontier to Be Explored.
    Cheng KH; Wu YW; Hou CJ; Hung CM
    Acta Cardiol Sin; 2021 Sep; 37(5):457-463. PubMed ID: 34584378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2.
    Manolis AA; Manolis TA; Mikhailidis DP; Manolis AS
    Expert Opin Drug Saf; 2018 Sep; 17(9):893-915. PubMed ID: 30126303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exercise as Medicine Could Be a Chance for Early Detection and Prevention of Cardiotoxicity in Cancer Treatments: A Narrative Review.
    Zoth N; Tomanek A; Seuthe K; Pfister R; Baumann FT
    Oncol Res Treat; 2023; 46(4):131-139. PubMed ID: 36652921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.